{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:29:50Z","timestamp":1792074590537,"version":"4.4.0"},"reference-count":80,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Bialystok","award":["B.SUB.25.272"],"award-info":[{"award-number":["B.SUB.25.272"]}]},{"name":"Medical University of Bialystok","award":["B.SUB.25.503"],"award-info":[{"award-number":["B.SUB.25.503"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Alzheimer\u2019s disease is the most common cause of dementia and one of the greatest challenges of current medicine. Its pathophysiology is complex, involving \u03b2-amyloid deposition, tau hyperphosphorylation, chronic neuroinflammation, and progressive neuronal loss. Despite the introduction of novel therapies, treatment efficacy remains limited, prompting the search for alternative therapeutic targets. One promising area of research focuses on matrix metalloproteinases-proteolytic enzymes involved in tissue remodeling, synaptic plasticity, and inflammatory responses. In the context of AD, MMPs may exert both protective effects, through amyloid degradation, and detrimental effects such as blood\u2013brain barrier disruption and amplification of neuroinflammatory damage. Understanding the dual and context-dependent roles of MMPs may help explain past translational failures and enable the development of more selective, stage-dependent therapeutic strategies. This article is a narrative review summarizing current evidence on the roles of MMPs in AD, with a particular focus on their therapeutic modulation and potential implications for future clinical research. Insights into MMP biology may ultimately guide the design of interventions with improved efficacy and safety for patients with AD.<\/jats:p>","DOI":"10.3390\/jcm15041555","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T08:38:39Z","timestamp":1771231119000},"page":"1555","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Potential Use of Matrix Metalloproteinases in Alzheimer\u2019s Disease Therapy"],"prefix":"10.3390","volume":"15","author":[{"given":"Daria","family":"Krawczuk","sequence":"first","affiliation":[{"name":"Department of Neurodegeneration Diagnostics, Medical University of Bialystok, Waszyngtona 15A, 15-269 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4075-8479","authenticated-orcid":false,"given":"Barbara","family":"Mroczko","sequence":"additional","affiliation":[{"name":"Department of Neurodegeneration Diagnostics, Medical University of Bialystok, Waszyngtona 15A, 15-269 Bia\u0142ystok, Poland"},{"name":"Department of Biochemical Diagnostics, Medical University of Bialystok, Waszyngtona 15A, 15-269 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/procel\/pwae026","article-title":"Alzheimer\u2019s disease: Insights into pathology, molecular mechanisms, and therapy","volume":"16","author":"Zheng","year":"2025","journal-title":"Protein Cell"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Passeri, E., Elkhoury, K., Morsink, M., Broersen, K., Linder, M., Tamayol, A., Malaplate, C., Yen, F.T., and Arab-Tehrany, E. (2022). Alzheimer\u2019s Disease: Treatment Strategies and Their Limitations. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213954"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1474-4422(09)70016-X","article-title":"Matrix metalloproteinases and their multiple roles in neurodegenerative diseases","volume":"8","author":"Rosenberg","year":"2009","journal-title":"Lancet Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Singh, D., Srivastava, S.K., Chaudhuri, T.K., and Upadhyay, G. (2015). Multifaceted role of matrix metalloproteinases (MMPs). Front. Mol. Biosci., 2.","DOI":"10.3389\/fmolb.2015.00019"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"15078","DOI":"10.1074\/jbc.M114.610931","article-title":"Sequential Amyloid-\u03b2 Degradation by the Matrix Metalloproteases MMP-2 and MMP-9","volume":"290","author":"Mawhirt","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"24566","DOI":"10.1074\/jbc.M602440200","article-title":"Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ","volume":"281","author":"Yan","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_8","first-page":"288","article-title":"Investigation of amyloid-\u03b2 peptide production and clearance pathways in different stages of Alzheimer\u2019s disease","volume":"84","author":"Sadeghi","year":"2024","journal-title":"Acta Neurobiol. Exp."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1021\/bi901994d","article-title":"Degradation of soluble and fibrillar amyloid beta-protein by matrix metalloproteinase (MT1-MMP) in vitro","volume":"49","author":"Liao","year":"2010","journal-title":"Biochemistry"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Rado\u0161insk\u00e1, D., Koll\u00e1rov\u00e1, M., Shawkatov\u00e1, I., \u010eurmanov\u00e1, V., P\u00e1rnick\u00e1, Z., Javor, J., Brandoburov\u00e1, P., Hars\u00e1nyi, \u0160., and Rado\u0161insk\u00e1, J. (2025). Impaired Oxidative Stress Markers and Activities of Matrix Metalloproteinases in Plasma of Patients with Alzheimer\u2019s Disease, Emphasizing Sex and APOE \u03b54 Allele Possession. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26188790"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neurobiolaging.2020.06.018","article-title":"Apolipoprotein E isoforms differentially regulate matrix metallopeptidase 9 function in Alzheimer\u2019s disease","volume":"95","author":"Ringland","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ba\u0161i\u0107, J., Milo\u0161evi\u0107, V., Djordjevi\u0107, B., Stojiljkovi\u0107, V., \u017divanovi\u0107, M., Stefanovi\u0107, N., Aracki Trenki\u0107, A., Stojanov, D., Jevtovi\u0107 Stoimenov, T., and Stojanovi\u0107, I. (2024). Matrix Remodeling Enzymes as Potential Fluid Biomarkers of Neurodegeneration in Alzheimer\u2019s Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25115703"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/WNL.53.7.1397","article-title":"Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis","volume":"53","author":"Waubant","year":"1999","journal-title":"Neurology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gendis.2019.02.004","article-title":"Matrix metalloproteinase 13, a new target for therapy in Alzheimer\u2019s disease","volume":"6","author":"Paumier","year":"2019","journal-title":"Genes Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Baranger, K., Bonnet, A.E., Girard, S.D., Paumier, J.-M., Garc\u00eda-Gonz\u00e1lez, L., Elmanaa, W., Bernard, A., Charrat, E., Stephan, D., and Bauer, C. (2017). MT5-MMP Promotes Alzheimer\u2019s Pathogenesis in the Frontal Cortex of 5xFAD Mice and APP Trafficking in vitro. Front. Mol. Neurosci., 9.","DOI":"10.3389\/fnmol.2016.00163"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Belio-Mairal, P., Kamitsou, A., Stephan, D., Jullien, N., Thiane, D., Louis, L., Benoist, F., Serrano, B., David, M., and Khrestchatisky, M. (2024). Mutations in specific domains of MT5-MMP prevent the accumulation of toxic APP metabolites and serve as templates for peptide-based therapeutics in human in vitro models of Alzheimer\u2019s disease. bioRxiv, hal-04642476.","DOI":"10.1101\/2025.05.22.655451"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00018-023-04737-4","article-title":"The \u03b7-secretase-derived APP fragment \u03b7CTF is localized in Golgi, endosomes and extracellular vesicles and contributes to A\u03b2 production","volume":"80","author":"Afram","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Jadhav, D., Knapinska, A.M., Wang, H., and Fields, G.B. (2025). Membrane-Type 5 Matrix Metalloproteinase (MT5-MMP): Background and Proposed Roles in Normal Physiology and Disease. Biomolecules, 15.","DOI":"10.3390\/biom15081114"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","article-title":"Tau and neuroinflammation in Alzheimer\u2019s disease: Interplay mechanisms and clinical translation","volume":"20","author":"Chen","year":"2023","journal-title":"J. Neuroinflamm."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JAD-142460","article-title":"Abnormal Expression and Distribution of MMP2 at Initial Stages of Alzheimer\u2019s Disease-Related Pathology","volume":"46","author":"Terni","year":"2015","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/brain\/awac329","article-title":"Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals","volume":"146","author":"Groot","year":"2023","journal-title":"Brain"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Song, L., Wells, E.A., and Robinson, A.S. (2021). Critical Molecular and Cellular Contributors to Tau Pathology. Biomedicines, 9.","DOI":"10.3390\/biomedicines9020190"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jocn.2010.01.005","article-title":"Matrix metalloproteinase-9 contributes to the increase of tau protein in serum during acute ischemic stroke","volume":"8","author":"Kurzepa","year":"2010","journal-title":"J. Clin. Neurosci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2174\/1570159X19666211202124925","article-title":"Ameliorating Alzheimer\u2019s-like Pathology by Minocycline via Inhibiting Cdk5\/p25 Signaling","volume":"20","author":"Zhao","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zhang, W.J., Li, D.N., Lian, T.H., Guo, P., Zhang, Y.-N., Li, J.-H., Guan, H.-Y., He, M.-Y., Zhang, W.-J., and Zhang, W.-J. (2022). Clinical Features and Potential Mechanisms Relating Neuropathological Biomarkers and Blood-Brain Barrier in Patients with Alzheimer\u2019s Disease and Hearing Loss. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.911028"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Kim, S., Jung, U.J., and Kim, S.R. (2025). The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications. J. Clin. Med., 14.","DOI":"10.3390\/jcm14020386"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/glia.20689","article-title":"A novel method to establish microglia-free astrocyte cultures: Comparison of matrix metalloproteinase expression profiles in pure cultures of astrocytes and microglia","volume":"56","author":"Crocker","year":"2008","journal-title":"Glia"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez, K., and Maguire-Zeiss, K. (2020). MMP13 Expression Is Increased Following Mutant \u03b1-Synuclein Exposure and Promotes Inflammatory Responses in Microglia. Front. Neurosci., 14.","DOI":"10.3389\/fnins.2020.585544"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12974-022-02407-z","article-title":"MT5-MMP promotes neuroinflammation, neuronal excitability and A\u03b2 production in primary neuron\/astrocyte cultures from the 5xFAD mouse model of Alzheimer\u2019s disease","volume":"19","author":"Pilat","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0271678X16655551","article-title":"Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers","volume":"36","author":"Rempe","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3233\/JAD-150759","article-title":"Matrix Metalloproteinase in Blood-Brain Barrier Breakdown in Dementia","volume":"49","author":"Weekman","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Di Lorenzo, R., Zecca, C., Chimienti, G., Latronico, T., Liuzzi, G.M., Pesce, V., Dell\u2019abate, M.T., Borlizzi, F., Giugno, A., and Urso, D. (2025). Reliable New Biomarkers of Mitochondrial Oxidative Stress and Neuroinflammation in Cerebrospinal Fluid and Plasma from Alzheimer\u2019s Disease Patients: A Pilot Study. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26167792"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.isci.2019.05.027","article-title":"Degradation of Extracellular Matrix by Matrix Metalloproteinase 2 Is Essential for the Establishment of the Blood-Brain Barrier in Drosophila","volume":"16","author":"Kanda","year":"2019","journal-title":"iScience"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-016-0779-0","article-title":"Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer\u2019s disease","volume":"14","author":"Moussa","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13195-022-01106-4","article-title":"Sex differences in Alzheimer\u2019s disease: Plasma MMP-9 and markers of disease severity","volume":"14","author":"Tsiknia","year":"2022","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/hr.2009.26","article-title":"The expression of matrix metalloproteinase-13 is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model","volume":"32","author":"Ueno","year":"2009","journal-title":"Hypertens. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.drudis.2016.09.023","article-title":"Marine pharmacology: Therapeutic targeting of matrix metalloproteinases in neuroinflammation","volume":"22","author":"Gentile","year":"2017","journal-title":"Drug Discov. Today"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/alzrt278","article-title":"First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer\u2019s disease model","volume":"6","author":"Kontsekova","year":"2014","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1017\/S1041610210000827","article-title":"Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer\u2019s disease","volume":"22","author":"Horstmann","year":"2010","journal-title":"Int. Psychogeriatr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3233\/JAD-131634","article-title":"Concentrations of matrix metalloproteinases and their tissue inhibitors in the cerebrospinal fluid of patients with Alzheimer\u2019s disease","volume":"40","author":"Mroczko","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Caldeira, C., Cunha, C., Vaz, A.R., Falc\u00e3o, A.S., Barateiro, A., Seixas, E., Fernandes, A., and Brites, D. (2017). Key Aging-Associated Alterations in Primary Microglia Response to Beta-Amyloid Stimulation. Front. Aging Neurosci., 9.","DOI":"10.3389\/fnagi.2017.00277"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"eadf5681","DOI":"10.1126\/scitranslmed.adf5681","article-title":"Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life","volume":"15","author":"Walker","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Behl, T., Kaur, G., Sehgal, A., Bhardwaj, S., Singh, S., Buhas, C., Judea-Pusta, C., Uivarosan, D., Munteanu, M.A., and Bungau, S. (2021). Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031413"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Paramakrishnan, N., Lim, K.G., Paramaswaran, Y., Ali, N., Waseem, M., Shazly, G.A., Bin Jardan, Y.A., and Muthuraman, A. (2023). Astaxanthin: A Marine Drug That Ameliorates Cerebrovascular-Damage-Associated Alzheimer\u2019s Disease in a Zebrafish Model via the Inhibition of Matrix Metalloprotease-13. Mar. Drugs, 21.","DOI":"10.3390\/md21080433"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/brain\/awy305","article-title":"MMP13 inhibition rescues cognitive decline in Alzheimer transgenic mice via BACE1 regulation","volume":"142","author":"Zhu","year":"2019","journal-title":"Brain"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Nguyen, Y.T., Kim, N., and Lee, H.J. (2023). Metal Complexes as Promising Matrix Metalloproteinases Regulators. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021258"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrd4390","article-title":"Is there new hope for therapeutic matrix metalloproteinase inhibition?","volume":"13","author":"Vandenbroucke","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"620581","DOI":"10.1155\/2015\/620581","article-title":"Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases","volume":"2015","author":"Brkic","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/cbf.2963","article-title":"Involvement of p38 MAPK in haemozoin-dependent MMP-9 enhancement in human monocytes","volume":"32","author":"Khadjavi","year":"2014","journal-title":"Cell Biochem. Funct."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10787-020-00772-w","article-title":"Neuroprotective potential of isothiocyanates in an in vitro model of neuroinflammation","volume":"2","author":"Latronico","year":"2021","journal-title":"Inflammopharmacology"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Sharifulina, S., Khaitin, A., Guzenko, V., Kalyuzhnaya, Y., Dzreyan, V., Logvinov, A., Dobaeva, N., Li, Y., Chen, L., and He, B. (2022). Expression of Amyloid Precursor Protein, Caveolin-1, Alpha-, Beta-, and Gamma-Secretases in Penumbra Cells after Photothrombotic Stroke and Evaluation of Neuroprotective Effect of Secretase and Caveolin-1 Inhibitors. Biomedicines, 10.","DOI":"10.3390\/biomedicines10102655"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1021\/bi972034y","article-title":"Alzheimer\u2019s amyloid precursor protein \u03b1-secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: \u2009Similarities to the angiotensin converting enzyme secretase","volume":"37","author":"Parvathy","year":"1998","journal-title":"Biochemistry"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s12031-017-0898-9","article-title":"Selection and Prioritization of Candidate Drug Targets for Amyotrophic Lateral Sclerosis Through a Meta-Analysis Approach","volume":"61","author":"Morello","year":"2017","journal-title":"J. Mol. Neurosci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.febslet.2006.02.052","article-title":"Epigallocatechin-3-gallate protects toluene diisocyanate-induced airway inflammation in a murine model of asthma","volume":"580","author":"Kim","year":"2006","journal-title":"FEBS Lett."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3892\/mmr.2014.1909","article-title":"Epigallocatechin-3-gallate inhibits the proliferation and migration of human ovarian carcinoma cells by modulating p38 kinase and matrix metalloproteinase-2","volume":"9","author":"Wang","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Tanabe, H., Suzuki, T., Ohishi, T., Isemura, M., Nakamura, Y., and Unno, K. (2023). Effects of Epigallocatechin-3-Gallate on Matrix Metalloproteinases in Terms of Its Anticancer Activity. Molecules, 28.","DOI":"10.3390\/molecules28020525"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"118159","DOI":"10.1016\/j.biopha.2025.118159","article-title":"Doxycycline: An essential tool for Alzheimer\u2019s disease","volume":"188","author":"Forloni","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.conctc.2017.08.012","article-title":"Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis","volume":"8","author":"Flynn","year":"2017","journal-title":"Contemp. Clin. Trials Commun."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Suzuki, T., Ohishi, T., Tanabe, H., Miyoshi, N., and Nakamura, Y. (2023). Anti-Inflammatory Effects of Dietary Polyphenols through Inhibitory Activity against Metalloproteinases. Molecules, 28.","DOI":"10.3390\/molecules28145426"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1019412","DOI":"10.3389\/fnagi.2022.1019412","article-title":"Small-molecule drugs development for Alzheimer\u2019s disease","volume":"14","author":"Yao","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"20234","DOI":"10.1021\/acsomega.3c01703","article-title":"Emergence of Small Interfering RNA-Based Gene Drugs for Various Diseases","volume":"8","author":"Kurakula","year":"2023","journal-title":"ACS Omega"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.34133\/bmr.0027","article-title":"Systemic Treatment with siRNA Targeting Gamma-Secretase Activating Protein Inhibits Amyloid-\u03b2 Accumulation in Alzheimer\u2019s Disease","volume":"28","author":"Kim","year":"2024","journal-title":"Biomater. Res."},{"key":"ref_64","first-page":"908636","article-title":"Matrix metalloproteinases and their multiple roles in Alzheimer\u2019s disease","volume":"2014","author":"Wang","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3233\/JAD-200146","article-title":"Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer\u2019s Disease","volume":"76","author":"Harrington","year":"2020","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/alzrt44","article-title":"Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer\u2019s disease","volume":"2","author":"Stomrud","year":"2010","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_67","first-page":"141","article-title":"Short hairpin RNA (shRNA): Design, delivery, and assessment of gene knockdown","volume":"629","author":"Moore","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"002127","DOI":"10.1099\/jgv.0.002127","article-title":"Translocating shRNA: A novel approach to RNA interference with Newcastle disease virus as viral vector","volume":"106","author":"Koh","year":"2025","journal-title":"J. Gen. Virol."},{"key":"ref_69","first-page":"1400","article-title":"Caspase-3 and GFAP as early markers for apoptosis and astrogliosis in shRNA-induced hippocampal cytotoxicity","volume":"220","author":"Luczak","year":"2017","journal-title":"J. Exp. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MS9.0000000000001500","article-title":"Application of CRISPR\/Cas9 in the management of Alzheimer\u2019s disease and Parkinson\u2019s disease: A review","volume":"86","author":"Thapar","year":"2023","journal-title":"Ann. Med. Surg."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1700611","DOI":"10.1002\/advs.201700611","article-title":"Exosome-Liposome Hybrid Nanoparticles Deliver CRISPR\/Cas9 System in MSCs","volume":"5","author":"Lin","year":"2018","journal-title":"Adv. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/bpa.12881","article-title":"Applying gene-editing technology to elucidate the functional consequence of genetic and epigenetic variation in Alzheimer\u2019s disease","volume":"30","author":"Schrauben","year":"2020","journal-title":"Brain Pathol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"33864","DOI":"10.18632\/oncotarget.13060","article-title":"Repetitive transcranial magnetic stimulation improves cognitive function of Alzheimer\u2019s disease patients","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Cirillo, G., Pepe, R., Siciliano, M., Ippolito, D., Ricciardi, D., de Stefano, M., Buonanno, D., Atripaldi, D., Abbadessa, S., and Perfetto, B. (2023). Long-Term Neuromodulatory Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Plasmatic Matrix Metalloproteinases (MMPs) Levels and Visuospatial Abilities in Mild Cognitive Impairment (MCI). Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043231"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e70337","DOI":"10.1002\/alz.70337","article-title":"The neurobiological foundation of effective repetitive transcranial magnetic brain stimulation in Alzheimer\u2019s disease","volume":"21","author":"Antonioni","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"14613","DOI":"10.1117\/1.NPh.12.S1.S14613","article-title":"Repetitive transcranial magnetic stimulation increases synaptic plasticity of cortical axons in the APP\/PS1 amyloidosis mouse model","volume":"12","author":"Fulopova","year":"2025","journal-title":"Neurophotonics"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Alkhalifa, A.E., Al-Ghraiybah, N.F., Odum, J., Shunnarah, J.G., Austin, N., and Kaddoumi, A. (2023). Blood-Brain Barrier Breakdown in Alzheimer\u2019s Disease: Mechanisms and Targeted Strategies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242216288"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41582-023-00809-y","article-title":"Single-cell and spatial transcriptomics: Deciphering brain complexity in health and disease","volume":"19","author":"Piwecka","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"ref_79","first-page":"164","article-title":"Combination Therapy of Anti-Tau and Anti-Amyloid Drugs for Disease Modification in Early-stage Alzhimer\u2019s Disease: Socio-economic Considerations Modeled on Treatments for Tuberculosis, HIV\/AIDS and Breast Cancer","volume":"3","author":"Tomaszewski","year":"2016","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"118457","DOI":"10.1016\/j.biopha.2025.118457","article-title":"The role of MMPs and TIMPs in regenerative medicine: From pathological ECM remodeling to therapeutic applications","volume":"191","author":"Kazemi","year":"2025","journal-title":"Biomed. Pharmacother."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/4\/1555\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:12:26Z","timestamp":1771391546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/4\/1555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":80,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["jcm15041555"],"URL":"https:\/\/doi.org\/10.3390\/jcm15041555","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]}}}